Middle East & Africa Radiation Oncology Market Forecast to 2031 - Regional Analysis

Description

List of Tables

The Middle East & Africa radiation oncology market was valued at US$ 172.24 million in 2023 and is expected to reach US$ 304.71 million by 2031; it is estimated to record a CAGR of 7.4% from 2023 to 2031.

Technological Advancement in Radiation Oncology Bolsters Middle East & Africa Radiation Oncology Market

Radiotherapy focuses on destroying the cancerous cells maximum sparing of healthy cells which was achieved over the period of time owing to the advancement in imaging technology such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) and others. These imaging technologies helps in identifying the tumors cells along with its exact position and size which led to the development of 3D conformal radiotherapy. Over the period of time, there is constant development in radiotherapy technologies as mentioned below

Flash Therapy: It is being discussed among healthcare professionals, rather than days or weeks the entire dose of massive radiation is delivered at once very quickly. The healthy cells recover well over the period of time and killing only cancer cells. It is under study and if it proves to be safe and effective it can be revolutionary radiation therapy in coming years.

Image-guided radiation therapy (IGRT): This technology allows for real-time imaging of the tumor and surrounding healthy tissue before each treatment session, ensuring that the radiation beams are accurately targeted at the tumor and minimizing damage to nearby organs.

Intensity-modulated radiation therapy (IMRT): IMRT allows for the delivery of varying intensities of radiation to different parts of the tumor, allowing for better dose distribution and sparing of healthy tissue.

Stereotactic body radiation therapy (SBRT): This technology delivers high doses of radiation to small, well-defined tumors in a limited number of treatment sessions, leading to better local control of the tumor.

Proton therapy: Proton therapy uses protons instead of traditional X-rays to deliver radiation to the tumor, allowing for more precise targeting of the tumor and sparing of healthy tissue.

Adaptive radiation therapy: This technology allows for adjustments to the treatment plan based on changes in the tumor size or position during the course of treatment, ensuring that the radiation dose is always optimized for maximum effectiveness.

Moreover, increasing integration of artificial intelligence (AI) in cancer treatment for treatment planning, labelling anatomy patient CT scan images, and others. AI will help to cater to the patient's requirements instantly by offering required solutions during the course of treatment. Additionally, various radiation therapy equipment is integrated with AI which will benefit the patient and healthcare professional both. For Instance, In May 2024, Elekta launched its latest linear accelerator (linac), Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments. Therefore, development in radiotherapy technologies and increasing integration of artificial intelligence is expected to expedite the radiation oncology market growth in coming years.

Middle East & Africa Radiation Oncology Market Overview

Over the past 50 years, Saudi Arabia has pioneered cancer care services in the Gulf region through several significant accomplishments. Progress in various cancer treatment areas aligns with its Vision 2030. Currently, Saudi Arabia has ~60 licensed radiation oncologists or clinical oncologists for treating patients with radiation therapy. The Saudi Proton Therapy Center at King Fahad Medical City in Riyadh became the first proton therapy facility in the Kingdom and the Arab world. The Saudi Fund for Development (SFD) opened the Saudi Radiotherapy Center for Cancer Patients at King Abdullah University Hospital in the northern Jordanian city of Ar-Ramtha in July 2021. This center helps over 1,200 cancer patients every year by providing essential services and enhancing healthcare in the northern part of Jordan.

Middle East & Africa Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

Middle East & Africa Radiation Oncology Market Segmentation

The Middle East & Africa radiation oncology market is categorized into types, application, and country.

Based on types, the Middle East & Africa radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

In terms of application, the Middle East & Africa radiation oncology market is segmented into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

By country, the Middle East & Africa radiation oncology market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, Provision Healthcare, Panacea Medical Technologies Pvt. Ltd, and Curium are some of the leading companies operating in the Middle East & Africa radiation oncology market.

Product Code: BMIRE00031008

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Middle East & Africa Radiation Oncology Market - Key Market Dynamics

4.1 Market Drivers:
- 4.1.1 Increasing Prevalence of Cancer
- 4.1.2 Initiatives to Support Developments in Radiation Oncology
4.2 Market Restraints
- 4.2.1 High Cost of Radiotherapy Equipment
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives in Radiation Oncology
4.4 Future Trends
- 4.4.1 Technological Advancement in Radiation Oncology
4.5 Impact of Drivers and Restraints:

5. Radiation Oncology Market - Middle East & Africa Market Analysis

5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

6. Middle East & Africa Radiation Oncology Market Analysis - by Types

6.1 External Beam Radiation Therapy
- 6.1.1 Overview
- 6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Internal Beam Radiation Therapy
- 6.2.1 Overview
- 6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

7. Middle East & Africa Radiation Oncology Market Analysis - by Application

7.1 Breast Cancer
- 7.1.1 Overview
- 7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Prostate Cancer
- 7.2.1 Overview
- 7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Lung Cancer
- 7.3.1 Overview
- 7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Head and Neck Cancer
- 7.4.1 Overview
- 7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Cervical Cancer
- 7.5.1 Overview
- 7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Radiation Oncology Market - Country Analysis

8.1 Middle East & Africa
- 8.1.1 Middle East & Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.1 Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.1.1 Saudi Arabia: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.1.2 Saudi Arabia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.1.3 Saudi Arabia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.1.4 Saudi Arabia: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.2 South Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.2.1 South Africa: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.2.2 South Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.2.3 South Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.2.4 South Africa: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.3 United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.3.1 United Arab Emirates: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.3.2 United Arab Emirates: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.3.3 United Arab Emirates: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.3.4 United Arab Emirates: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.4 Rest of Middle East & Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.4.1 Rest of Middle East & Africa: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.4.2 Rest of Middle East & Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.4.3 Rest of Middle East & Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.4.4 Rest of Middle East & Africa: Radiation Oncology Market Breakdown, by Application

9. Radiation Oncology Market - Industry Landscape

9.1 Overview
9.2 Growth Strategies in Radiation Oncology Market
9.3 Organic Growth Strategies
- 9.3.1 Overview
9.4 Inorganic Growth Strategies
- 9.4.1 Overview

10. Company Profiles

10.1 Varian Medical Systems Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview (Siemens Healthineers AG)
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Elekta AB
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Accuray Incorporated
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 IBA Worldwide (Ion Beam Applications SA)
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Becton Dickinson and Co
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 Perspective Therapeutics Inc
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Nordion
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Mevion Medical Systems
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 NTP RADIOISOTOPES
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Mallinckrodt Plc
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments
10.11 Provision Healthcare
- 10.11.1 Key Facts
- 10.11.2 Business Description
- 10.11.3 Products and Services
- 10.11.4 Financial Overview
- 10.11.5 SWOT Analysis
- 10.11.6 Key Developments
10.12 Panacea Medical Technologies Pvt. Ltd
- 10.12.1 Key Facts
- 10.12.2 Business Description
- 10.12.3 Products and Services
- 10.12.4 Financial Overview
- 10.12.5 SWOT Analysis
- 10.12.6 Key Developments
10.13 Curium
- 10.13.1 Key Facts
- 10.13.2 Business Description
- 10.13.3 Products and Services
- 10.13.4 Financial Overview
- 10.13.5 SWOT Analysis
- 10.13.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms